| Craig Volpe, OD | |
|
5399 Williston Rd Ste 102, Williston, VT 05495-5321 | |
| (802) 864-5428 | |
| Not Available |
| Full Name | Craig Volpe |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 8 Years |
| Location | 5399 Williston Rd Ste 102, Williston, Vermont |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013441666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 030.0121630 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Francis L Pinard Od Pc | 6709092596 | 5 |
News Archive
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Osteoarthritis is a leading cause of disability in the United States, affecting 27 million Americans. In an effort to raise awareness and increase knowledge of OA among the nursing community, Hospital for Special Surgery, the American Journal of Nursing and the National Association of Orthopaedic Nurses will present a groundbreaking two-day symposium: "State-of-the-Science in the Prevention and Management of Osteoarthritis" on Thursday, July 14, and Friday, July 15.
Today, ZEISS introduces a new inverted microscope platform for life science research. The ZEISS Axio Observer family consists of three stable and modular microscope stands for flexible and efficient imaging. Scientists benefit from reproducible results from their experiments and high quality image data from a whole range of samples in a variety of conditions. ZEISS Axio Observer combines the proven quality of ZEISS optics with new automation features, allowing researchers to perform demanding multimodal imaging of living and fixed specimens.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
› Verified 2 days ago
| Provider Name | Francis L Pinard Od Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053589374 PECOS PAC ID: 6709092596 Enrollment ID: O20130927000604 |
News Archive
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Osteoarthritis is a leading cause of disability in the United States, affecting 27 million Americans. In an effort to raise awareness and increase knowledge of OA among the nursing community, Hospital for Special Surgery, the American Journal of Nursing and the National Association of Orthopaedic Nurses will present a groundbreaking two-day symposium: "State-of-the-Science in the Prevention and Management of Osteoarthritis" on Thursday, July 14, and Friday, July 15.
Today, ZEISS introduces a new inverted microscope platform for life science research. The ZEISS Axio Observer family consists of three stable and modular microscope stands for flexible and efficient imaging. Scientists benefit from reproducible results from their experiments and high quality image data from a whole range of samples in a variety of conditions. ZEISS Axio Observer combines the proven quality of ZEISS optics with new automation features, allowing researchers to perform demanding multimodal imaging of living and fixed specimens.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig Volpe, OD 5399 Williston Rd Ste 102, Williston, VT 05495-5321 Ph: (802) 864-5428 | Craig Volpe, OD 5399 Williston Rd Ste 102, Williston, VT 05495-5321 Ph: (802) 864-5428 |
News Archive
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Osteoarthritis is a leading cause of disability in the United States, affecting 27 million Americans. In an effort to raise awareness and increase knowledge of OA among the nursing community, Hospital for Special Surgery, the American Journal of Nursing and the National Association of Orthopaedic Nurses will present a groundbreaking two-day symposium: "State-of-the-Science in the Prevention and Management of Osteoarthritis" on Thursday, July 14, and Friday, July 15.
Today, ZEISS introduces a new inverted microscope platform for life science research. The ZEISS Axio Observer family consists of three stable and modular microscope stands for flexible and efficient imaging. Scientists benefit from reproducible results from their experiments and high quality image data from a whole range of samples in a variety of conditions. ZEISS Axio Observer combines the proven quality of ZEISS optics with new automation features, allowing researchers to perform demanding multimodal imaging of living and fixed specimens.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
› Verified 2 days ago
David W. Beeson, O.d., P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 863 Harvest Ln, Williston, VT 05495 Phone: 802-878-2633 Fax: 802-878-4636 | |
Argjenta Orana, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5399 Williston Rd Ste 102, Williston, VT 05495 Phone: 802-864-5428 Fax: 802-865-1288 | |
Dr. Charles Robert Cyr, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5399 Williston Rd, Ste 102, Williston, VT 05495 Phone: 802-864-5428 | |
Dr. Thomas H Clark, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 33 Blair Park Rd, Suite 101, Williston, VT 05495 Phone: 802-862-1947 Fax: 802-878-4874 | |
Dr. Alexander Van Dyck, OD Optometrist Medicare: Medicare Enrolled Practice Location: 5399 Williston Rd Ste 102, Williston, VT 05495 Phone: 802-864-5428 | |
Dr. David Wesley Beeson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 863 Harvest Ln, Williston, VT 05495 Phone: 802-878-2633 Fax: 802-878-4636 |